Demyelinating polyradiculoneuritis in patients with multiple myeloma: the other side of bortezomib-induced neurotoxicity
Academic Article
Publication Date:
2020
Iris type:
1.1.2. Articolo in Rivista - Letter, Note
Keywords:
Aged; Antineoplastic Agents; Bortezomib; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multiple Myeloma; Polyradiculoneuropathy; Prognosis; Retrospective Studies; Survival Rate
List of contributors:
Gendreau, S.; Berzero, G.; Tafani, C.; Raynouard, I.; Ricard, D.; Malfuson, J. -V.; Viala, K.; Debs, R.; Houillier, C.; Diamanti, L.; Marchioni, E.; Lenglet, T.; Ouzegdouh, M.; Bihan, K.; Gilardin, L.; Psimaras, D.
Published in: